• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surgical Second Opinion for Pancreatic Cancer Patients.胰腺癌患者的手术二次诊断意见
J Am Coll Surg. 2025 Mar 1;240(3):270-278. doi: 10.1097/XCS.0000000000001213. Epub 2025 Feb 14.
2
Robotic distal pancreatectomy reduces pancreatic fistula in patients without visceral obesity as compared to open distal pancreatectomy: A propensity score matching retrospective cohort study.机器人辅助远端胰腺切除术与开腹远端胰腺切除术相比,可减少非肥胖型内脏患者的胰瘘:一项倾向评分匹配回顾性队列研究。
Int J Surg. 2021 Jun;90:105960. doi: 10.1016/j.ijsu.2021.105960. Epub 2021 May 12.
3
Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.伴有同步肝转移的胰腺导管腺癌的术前评估:不可切除性的诊断与评估
World J Gastroenterol. 2016 Dec 7;22(45):10024-10037. doi: 10.3748/wjg.v22.i45.10024.
4
A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer.胰腺切除术后无并发症有助于提高胰腺癌患者的长期生存率。
Pancreatology. 2019 Jul;19(5):686-694. doi: 10.1016/j.pan.2019.06.012. Epub 2019 Jun 22.
5
Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.荷兰胰腺导管腺癌远端胰腺切除术的结果:一项全国性回顾性分析
Ann Surg Oncol. 2016 Feb;23(2):585-91. doi: 10.1245/s10434-015-4930-4. Epub 2015 Oct 27.
6
Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.残胰复发性胰腺导管腺癌的二次胰腺切除术:一项汇总分析。
Pancreatology. 2016 Nov-Dec;16(6):1124-1128. doi: 10.1016/j.pan.2016.09.015. Epub 2016 Sep 29.
7
Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.腹腔镜与开放远端胰腺切除术治疗胰腺导管腺癌:一项单中心倾向评分匹配研究
Updates Surg. 2020 Jun;72(2):387-397. doi: 10.1007/s13304-020-00742-5. Epub 2020 Apr 8.
8
Predictive value of perioperative fasting blood glucose for post pancreatectomy diabetes mellitus in pancreatic ductal carcinoma patients.围手术期空腹血糖对胰导管腺癌患者胰腺切除术后糖尿病的预测价值
World J Surg Oncol. 2025 Feb 15;23(1):55. doi: 10.1186/s12957-025-03705-5.
9
Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.糖尿病对胰腺腺癌切除术后围手术期结局的影响。
J Am Coll Surg. 2010 Apr;210(4):463-73. doi: 10.1016/j.jamcollsurg.2009.12.029.
10
Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.血管切除治疗局部进展期胰导管腺癌:单中心系列长期结果分析。
World J Surg Oncol. 2021 Apr 18;19(1):126. doi: 10.1186/s12957-021-02238-x.

本文引用的文献

1
Pancreatic Cancer Multidisciplinary Clinic is Associated with Improved Treatment and Elimination of Socioeconomic Disparities.胰腺癌多学科诊疗与改善治疗及消除社会经济差异相关。
Ann Surg Oncol. 2024 Mar;31(3):1906-1915. doi: 10.1245/s10434-023-14609-7. Epub 2023 Nov 21.
2
Mortality and Severe Complications Among Newly Graduated Surgeons in the United States.美国新毕业外科医生的死亡率和严重并发症情况
Ann Surg. 2024 Apr 1;279(4):555-560. doi: 10.1097/SLA.0000000000006128. Epub 2023 Oct 13.
3
Nationwide Outcomes of Pancreaticoduodenectomy for Pancreatic Malignancies: Center Volume Matters.全国范围内胰腺恶性肿瘤胰十二指肠切除术的结果:中心容量很重要。
Am Surg. 2023 Dec;89(12):6020-6029. doi: 10.1177/00031348231184198. Epub 2023 Jun 13.
4
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience.多学科肿瘤委员会(MDTB)在胰腺癌诊断及可切除性评估中的作用:一家三级转诊中心的经验
Front Surg. 2023 Feb 17;10:1119557. doi: 10.3389/fsurg.2023.1119557. eCollection 2023.
5
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A nationwide analysis.多中心诊断性检查对胰腺癌患者重复诊断检查、诊断时间和治疗时间的影响:一项全国性分析。
Eur J Surg Oncol. 2022 Oct;48(10):2195-2201. doi: 10.1016/j.ejso.2022.05.031. Epub 2022 Jun 2.
7
Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis.老年胰腺癌患者的短期和长期预后:一项全国性分析。
Ann Surg Oncol. 2022 Sep;29(9):6031-6042. doi: 10.1245/s10434-022-11831-7. Epub 2022 Jun 2.
8
How Referring Providers Choose Specialists for Their Patients: a Systematic Review.介绍医生如何为患者选择专家:系统评价。
J Gen Intern Med. 2022 Oct;37(13):3444-3452. doi: 10.1007/s11606-022-07574-6. Epub 2022 Apr 19.
9
Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analysis.胰腺癌切除术后患者数量和临床结局:当代系统评价和荟萃分析。
Surgery. 2022 Jul;172(1):273-283. doi: 10.1016/j.surg.2021.11.029. Epub 2022 Jan 14.
10
Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?教科书式的胰十二指肠切除术肿瘤学结果:区域化努力有意义吗?
J Surg Oncol. 2022 Mar;125(3):414-424. doi: 10.1002/jso.26712. Epub 2021 Oct 7.

胰腺癌患者的手术二次诊断意见

Surgical Second Opinion for Pancreatic Cancer Patients.

作者信息

Quinn Patrick L, Nikahd Melica, Saiyed Shah, Heifetz Addie, Bath Natalie M, Hyer J Madison, Cloyd Jordan M, Jain Shikha, Ejaz Aslam

机构信息

From the Division of Surgical Oncology, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, OH (Quinn, Nikahd, Bath, Hyer, Cloyd).

University College Dublin, Dublin, Ireland (Saiyed).

出版信息

J Am Coll Surg. 2025 Mar 1;240(3):270-278. doi: 10.1097/XCS.0000000000001213. Epub 2025 Feb 14.

DOI:10.1097/XCS.0000000000001213
PMID:39297812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11828680/
Abstract

BACKGROUND

Due to the complexity of pancreatic surgery, patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) may seek out the opinion of more than 1 surgeon. Little is known regarding how second surgical opinions impact the likelihood of pancreatectomy and perioperative outcomes. Our study aimed to determine the impact of obtaining second surgical opinions on pancreatectomy rates and to assess its impact on surgical outcomes.

STUDY DESIGN

Patients who were diagnosed with PDAC between 2013 and 2020 were identified using 100% Medicare Inpatient and Outpatient Standard Analytic Files. Data collected included the number of surgeons consulted and geographic region. Receipt of pancreatectomy and perioperative outcomes were compared between patients who received only 1 and more than 1 surgical consultation.

RESULTS

Of 116,072 patients diagnosed with PDAC, 10,640 (9.2%) underwent pancreatectomy. A total of 4,913 (4.2%) patients received a second surgical opinion, of whom 1,906 (17.9%) patients underwent pancreatectomy after the second opinion visit. Patients receiving a second surgical opinion were more likely to undergo pancreatectomy (adjusted odds ratio 6.17; 95% CI 5.78 to 6.59). Patients who received a second opinion and underwent surgery had equivalent length of stay and complication rates compared to those who underwent surgery without seeking a second opinion (both p > 0.05).

CONCLUSIONS

Among Medicare patients who underwent pancreatectomy for pancreatic cancer, approximately 1 in 7 patients received a second surgical opinion. Further research is needed to determine how patient motivations, referral patterns, disease characteristics, and treatments all interplay to affect clinical outcomes for patients undergoing pancreatectomy for PDAC.

摘要

背景

由于胰腺手术的复杂性,被诊断为胰腺导管腺癌(PDAC)的患者可能会寻求不止一位外科医生的意见。关于第二种手术意见如何影响胰腺切除术的可能性和围手术期结果,目前知之甚少。我们的研究旨在确定获得第二种手术意见对胰腺切除率的影响,并评估其对手术结果的影响。

研究设计

使用100%的医疗保险住院和门诊标准分析文件,确定2013年至2020年间被诊断为PDAC的患者。收集的数据包括咨询的外科医生数量和地理区域。比较仅接受一次手术咨询和接受不止一次手术咨询的患者的胰腺切除术接受情况和围手术期结果。

结果

在116,072例被诊断为PDAC的患者中,10,640例(9.2%)接受了胰腺切除术。共有4,913例(4.2%)患者获得了第二种手术意见,其中1,906例(17.9%)患者在第二次意见就诊后接受了胰腺切除术。接受第二种手术意见的患者更有可能接受胰腺切除术(调整后的优势比为6.17;95%置信区间为5.78至6.59)。与未寻求第二种意见而接受手术的患者相比,接受第二种意见并接受手术的患者住院时间和并发症发生率相当(两者p>0.05)。

结论

在因胰腺癌接受胰腺切除术的医疗保险患者中,约七分之一的患者获得了第二种手术意见。需要进一步研究以确定患者动机、转诊模式、疾病特征和治疗如何相互作用,从而影响因PDAC接受胰腺切除术的患者的临床结果。